Who's Who
Catherine De Martel
Visiting Scientist
Infections and Cancer Epidemiology Group
Specialty:
EpidemiologyAcademic Degrees
| Year | Degree | Major | Institution | Town | Country |
|---|---|---|---|---|---|
| 2005 | Phd | Epidemiology | Stanford University | Stanford CA | USA |
| 2001 | Master of Science | Epidemiology | Stanford University | Stanford CA | USA |
| 1999 | C1-C2 Certificates | Biostatistics | Paris Sud University | Paris | France |
| 1994 | MD | Medicine | Bichat Claude Bernard University | Paris | France |
Current Research Projects
- Infections and precancerous lesions of the gallbladder (Acronym : ICE-Bile)
IARC (Coordinator) - Filling the gaps in the epidemiology of human papillomavirus and cervical cancer in developing countries
IARC (Coordinator) - Meta-analyses of HPV prevalence and type distribution in neoplastic diseases
IARC (Coordinator) - Burden of cancer attributable to infections
IARC (Coordinator) - Cancers attributable to infections in the HIV population
IARC (Co-partner)
Selected Publications
de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M. (2012) The global burden of cancers attributable to infections in the year 2008: a review and synthetic analysis. Lancet Oncol , in pressde Martel C, Plummer M, van Doorn LJ, Vivas J, Lopez G, Carillo E, Peraza S, Muñoz N, Franceschi S. (2010) Comparison of polymerase chain reaction and histopathology for the detection of Helicobacter pylori in gastric biopsies. Int J Cancer 126 : 1992-1996
de Martel C, Plummer M, Parsonnet J, van Doorn LJ, Franceschi S. (2009) Helicobacter species in cancers of the gallbladder and extrahepatic biliary tract. Br J Cancer 100 : 194-199
de Martel C, Llosa AE, Friedman GD, Vogelman JH, Orentreich N, Stolzenberg-Solomon RZ, Parsonnet J. (2008) Helicobacter pylori infection and development of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 17 : 1188-1194
de Martel C, Llosa AE, Farr SM, Friedman GD, Vogelman JH, Orentreich N, Corley DA, Parsonnet J. (2005) Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis 191 : 761-767